|
C14ORF43 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.4026999999881E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12740000002276E-06 |
| Normal-vs-Stage2 |
2.480800E-03 |
| Normal-vs-Stage3 |
5.97710000049823E-07 |
| Normal-vs-Stage4 |
3.61270000026614E-07 |
| Stage1-vs-Stage2 |
5.777400E-01 |
| Stage1-vs-Stage3 |
9.850000E-02 |
| Stage1-vs-Stage4 |
3.943700E-02 |
| Stage2-vs-Stage3 |
8.270000E-02 |
| Stage2-vs-Stage4 |
5.427700E-02 |
| Stage3-vs-Stage4 |
6.608400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.49010000000316E-06 |
| Normal-vs-AfricanAmerican |
1.838480E-02 |
| Normal-vs-Asian |
1.583670E-04 |
| Caucasian-vs-AfricanAmerican |
3.986400E-01 |
| Caucasian-vs-Asian |
7.863400E-01 |
| AfricanAmerican-vs-Asian |
5.550000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.14159999997643E-06 |
| Normal-vs-Female |
2.09940000051034E-07 |
| Male-vs-Female |
2.099400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.84481999999653E-05 |
| Normal-vs-Age(41-60Yrs) |
8.38119999957421E-07 |
| Normal-vs-Age(61-80Yrs) |
2.88329999986736E-07 |
| Normal-vs-Age(81-100Yrs) |
2.555500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.336400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.305900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.430200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.622590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.298400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.000200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.614400E-04 |
| Classical-VS-Follicular |
2.123600E-01 |
| Classical-VS-Other |
3.446400E-01 |
| Classical-VS-Normal |
1.198630E-04 |
| Tall-VS-Follicular |
6.589600E-02 |
| Tall-VS-Other |
6.519000E-01 |
| Tall-VS-Normal |
5.16970000141725E-08 |
| Follicular-VS-Other |
6.604200E-01 |
| Follicular-VS-Normal |
2.17259999999442E-05 |
| Other-VS-Normal |
2.279700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.84840000031039E-07 |
| Normal-vs-N1 |
2.46549999971535E-07 |
| N0-vs-N1 |
8.319500E-02 |
|
|
